United Therapeutics | UTHR - Interest Income

Stock Price
568.58
Daily Change
-7.21 -1.25%
Monthly
-2.06%
Yearly
86.21%
Q2 Forecast
553.25

United Therapeutics reported $43.2M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Amarin USD 3.37M 3.37M Dec/2024
Baxter International USD 11M 1000K Dec/2025
Bayer EUR 169M 39M Dec/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Biogen USD 37.9M 700K Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 2.14 237M Mar/2026
Moderna USD 70M 3M Dec/2025
Pfizer USD 115M 51M Mar/2026
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sarepta Therapeutics USD 8.74M 359K Dec/2025
United Therapeutics USD 43.2M 3.2M Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026